• IEM 1460: AMPA Receptor Blocker Workflows & Troubleshooting

  2026-06-29

  IEM 1460 is a selective AMPA receptor blocker enabling precise dissection of synaptic mechanisms and neuroprotection pathways in neuroscience research. This guide details protocol optimization, advanced experimental uses, and troubleshooting strategies—bridging foundational AMPA inhibition assays to translational models of excitotoxic injury.

• Formononetin Shields Neurons from Oxaliplatin Neurotoxicity

  2026-06-29

  This study demonstrates that formononetin protects sensory neurons from oxaliplatin-induced peripheral neurotoxicity by activating the Nrf2/HO-1 antioxidant pathway, crucially without reducing the anticancer efficacy of oxaliplatin or paclitaxel. The findings address a critical challenge in chemotherapy-induced neuropathy management and inform protocol design for neuroprotection without compromising cancer treatment.

• D-N-Acetylgalactosamine: Protocols for Brain Glycoprotein An

  2026-06-28

  D-N-Acetylgalactosamine is a high-purity, water-soluble metabolite optimized for dissecting glycoprotein structures and glycosylation pathways in brain tissue research. It should be avoided in protocols requiring ethanol solubility or long-term solution storage. This guide summarizes practical workflow parameters and QC steps for reliable experimental setup.

• Endogenous H2S Deficiency Drives ER Stress in Diabetic Cardi

  2026-06-27

  This study reveals that diminished endogenous hydrogen sulfide (H2S) production is a key driver of endoplasmic reticulum (ER) stress and lipotoxic myocardial injury in diabetic cardiomyopathy (DCM). Restoration of H2S, either in vitro or in vivo, alleviates ER stress and cardiac dysfunction, highlighting a mechanistic axis relevant for experimental modeling and therapeutic targeting.

• Ibrutinib (PCI-32765) for Precision B-Cell Signaling Researc

  2026-06-26

  Ibrutinib (PCI-32765) delivers highly selective, irreversible BTK inhibition, making it the gold standard for dissecting B-cell receptor signaling in chronic lymphocytic leukemia and autoimmune disease models. Explore stepwise protocols, advanced troubleshooting, and unique insights from reference studies to maximize reproducibility and data clarity.

• Belinostat (PXD101): HDAC Inhibition in Cancer Research Work

  2026-06-26

  Belinostat (PXD101) is a potent pan-HDAC inhibitor that empowers researchers to dissect epigenetic mechanisms and cell cycle arrest in diverse cancer models. This article maps out actionable protocols, advanced use-cases, and troubleshooting strategies—bridging published insights and real-lab optimization for reproducible, data-driven cancer research.

• Integrating Stromal Cells in Gastric Cancer Assembloids for

  2026-06-25

  This study establishes a patient-derived gastric cancer assembloid model that co-cultures matched tumor organoids with stromal cell subpopulations, capturing microenvironmental complexity. The model reveals how stromal context modulates gene expression and drug sensitivity, providing a robust platform for preclinical drug screening and personalized medicine.

• Structural Insights into ASCH Domain Proteins and ac4C Proce

  2026-06-25

  Meng et al. provide a detailed structural and mechanistic analysis of ASCH domain-containing proteins, with a focus on EcYqfB’s specificity for N4-acetylcytidine nucleoside hydrolysis. Their work clarifies the catalytic mechanism of EcYqfB, its substrate selectivity, and the broader implications for RNA modification and nucleotide metabolism research.

• Dovitinib (TKI-258): Illuminating RTK-Driven Metastasis Mech

  2026-06-24

  Explore how Dovitinib (TKI-258) uniquely enables research on the interplay between receptor tyrosine kinase signaling and metastatic niche formation. This in-depth article reveals new assay strategies, mechanistic insights, and practical parameters for advanced cancer biology studies.

• CCR7–Notch1 Crosstalk Drives Stemness in Mammary Cancer Cell

  2026-06-23

  Boyle et al. (2017) reveal functional interplay between CCR7 and Notch1 signaling that promotes stemness in MMTV-PyMT mammary cancer cells. Their work highlights the importance of targeting both axes to disrupt the cancer stem cell population and suggests potential routes for therapeutic intervention in breast cancer.

• QNZ (EVP4593): Potent NF-κB Inhibitor for Disease Modeling

  2026-06-23

  QNZ (EVP4593) is a nanomolar-potency quinazoline derivative that selectively inhibits the NF-κB signaling pathway, exhibiting robust anti-inflammatory and neuroprotective effects. Its validated use in inflammation and Huntington’s disease research is supported by distinct, reproducible molecular and functional benchmarks.

• Marein Restores Chemosensitivity by Inhibiting ABCG2 in Canc

  2026-06-22

  This study uncovers marein, a flavonoid from Coreopsis tinctoria, as a novel competitive inhibitor of the ABCG2 transporter, effectively reversing multidrug resistance in cancer cells. These findings highlight new avenues for overcoming resistance to chemotherapeutics such as mitoxantrone and inform combination therapy strategies in oncology research.

• Cytokine and Glucocorticoid Regulation of BIRC2/3 in Lung Ep

  2026-06-22

  This study delineates how inflammatory cytokines and glucocorticoids differentially regulate BIRC2 and BIRC3 expression in human pulmonary epithelial cells. The findings clarify the distinct signaling roles of these IAP family members, with implications for understanding epithelial responses to inflammation and steroid therapy.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Techn

  2026-06-21

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) addresses protein degradation during extraction and analysis by inhibiting multiple protease classes without interfering with divalent cation-dependent assays. This product should be used when broad-spectrum protease inhibition is required, but is not suitable for protocols needing EDTA-mediated chelation or where DMSO is incompatible.

• Sphingosine-1-phosphate in Vascular Maturation and Apoptosis

  2026-06-20

  Leverage Sphingosine-1-phosphate (S1P) for advanced studies in cell proliferation, apoptosis, and vascular biology. This guide delivers optimized experimental protocols and troubleshooting insights, bridging the latest mechanistic findings with practical workflows.

451 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page